|
|
|||||||
| Nitrite (μM); mean ± SEM |
|||||||
|
|
|||||||
| Control |
Concentration of peptide alone |
1 μg/ml LPS with stated concentration of peptides below |
|||||
| 10 μM |
100 μM |
0 μM |
1 μM |
10 μM |
100 μM |
||
|
|
|||||||
| MALY O1 |
0.70 |
2.00 |
0.77 |
44.6 |
46.1 |
47.2 |
51.6 |
| ± 0.2 |
± 1.6 |
± 0.3 |
± 2.7 |
± 4.2 |
± 5.1 |
± 2.0 |
|
| MALY 1O |
0.70 |
0.87 |
0.85 |
44.6 |
47.3 |
40.3 |
46.4 |
| ± 0.2 |
± 0.4 |
± 0.3 |
± 3.3 |
± 0.8 |
± 1.9 |
± 0.9 |
|
| MALY II |
0.70 |
0.64 |
0.66 |
44.6 |
46.2 |
43.4 |
45.9 |
| ± 0.2 |
± 0.3 |
± 0.3 |
± 2.8 |
± 0.9 |
± 2.9 |
± 0.5 |
|
|
RAW cells were stimulated with medium alone (control), LPS (1 μg/ml) or various concentrations of the MALY TAT-linked PKC translocation inhibitor peptides (MALYO1 = cPKC inhibitor, MALY1O = PKC specific, MALYII = scrambled PKC inhibitor peptide), with or without LPS for 24 hr. NO production was assessed by Greiss assay. Results represent mean ± SEM (n= 3) and are representative of two separate experiments. | |||||||
Jones et al. Journal of Inflammation 2007 4:23 doi:10.1186/1476-9255-4-23 |
|||||||